Despite differences in types of infection and causative organisms, pharmacokinetic-pharmacodynamic (PKPD) targets of vancomycin therapy derived from adult studies are suggested for neonates. | Coagulase negative staphylococcal sepsis in neonates: Do we need to adapt vancomycin dose or target?